| Period | 5 Dec 2013 |
|---|---|
| Held at | Karolinska Institute Medical Biochemistry and Biophysics, Sweden |
Related content
-
Publications
-
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Research output: Contribution to journal › Article › peer-review
-
Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors
Research output: Contribution to journal › Article › peer-review
-
Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs
Research output: Contribution to journal › Article › peer-review
-
Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach
Research output: Contribution to journal › Article › peer-review
-
N-Myristoyltransferase from Leishmania donovani: Structural and Functional Characterisation of a Potential Drug Target for Visceral Leishmaniasis
Research output: Contribution to journal › Article › peer-review
-
Projects
-
N-Myristol Transferase as a drug target for anti-malarial therapy
Project: Research project (funded) › Research